Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

Transplant Proc. 2001 Feb-Mar;33(1-2):1013-4. doi: 10.1016/s0041-1345(00)02309-5.
No abstract available

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Cadaver
  • Child
  • Child, Preschool
  • Daclizumab
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use*
  • Graft Rejection / prevention & control*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use*
  • Tacrolimus / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Daclizumab
  • Mycophenolic Acid
  • Tacrolimus
  • Methylprednisolone